Cart
sales@molnova.com
MYF-01-37
CAS No. 2416417-65-5
MYF-01-37( 1-[3-Methyl-3-[3-(trifluoromethyl)anilino]pyrrolidin-1-yl]prop-2-en-1-one )
Catalog No. M24113 CAS No. 2416417-65-5
MYF-01-37 is a novel covalent TEAD inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 58 | In Stock |
|
| 2MG | 32 | In Stock |
|
| 5MG | 52 | In Stock |
|
| 10MG | 92 | In Stock |
|
| 25MG | 169 | In Stock |
|
| 50MG | 291 | In Stock |
|
| 100MG | 435 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 918 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMYF-01-37
-
NoteResearch use only, not for human use.
-
Brief DescriptionMYF-01-37 is a novel covalent TEAD inhibitor.
-
DescriptionMYF-01-37 is a novel covalent TEAD inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms1-[3-Methyl-3-[3-(trifluoromethyl)anilino]pyrrolidin-1-yl]prop-2-en-1-one
-
PathwayOthers
-
TargetOther Targets
-
RecptorTEAD
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2416417-65-5
-
Formula Weight298.3
-
Molecular FormulaC15H17F3N2O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (838.08 mM)
-
SMILESCC(CC1)(CN1C(C=C)=O)Nc1cccc(C(F)(F)F)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kurppa K J , Liu Y , To C , et al. Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway[J]. Cancer Cell, 2020, 37(1):104-122.e12.
molnova catalog
related products
-
Dimethyl nonanedioat...
Dimethyl nonanedioate (Standard) is the analytical standard of Dimethyl nonanedioate. This product is intended for research and analytical applications. Dimethyl nonanedioate (Nonanedioic acid dimethyl ester) is an ester product.
-
m-Nisoldipine
m-Nisoldipine is a chemical compound.
-
Taurocholic acid
Taurocholic acid is a bile acid involved in the emulsification of fats.Taurocholic acid is cytoprotective, preventing tumor necrosis factor-alpha-induced cholangiocyte damage via a PI3K-mediated pathway.
